No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 5 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for iTonic Holdings Ltd. (ITOC) stock was $4.08 as of Oct 6, 2026, 11:05 AM EDT, up 0.55% from the previous close.
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size.
Medical - Specialties · Beijing, BE
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$100906.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ITOC | $2.39M | $4.08 | +0.55% | N/A | N/A | N/A | N/A |
| 2CELZ | $2.32M | $0.90 | -2.17% | -71.43% | -57.96% | -72.19% | vs ITOC |
| 3MBRX | $2.47M | $0.46 | -3.04% | -95.81% | -78.48% | -64.00% | vs ITOC |
| 4ONCO | $2.26M | $0.63 | -6.17% | -99.55% | N/A | N/A | vs ITOC |
| 5GOVX | $2.26M | $0.31 | -4.03% | N/A | N/A | N/A | vs ITOC |
| 6FBLG | $2.55M | $1.21 | +2.95% | -89.14% | N/A | N/A | vs ITOC |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$4.08
High
N/A
